Exfoliation syndrome: Beyond glaucoma

Archives of Ophthalmology

Volumn 126, Issue 6, 2008, Pages 859-861

  Ritch, Robert ^a  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; ENDOTHELIN 1; HOMOCYSTEINE; LATANOPROST; PROTEIN LYSINE 6 OXIDASE; TRANSFORMING GROWTH FACTOR BETA1;

BLOOD VESSEL WALL; CATARACTOGENESIS; CILIARY ARTERY; COLOR ULTRASOUND FLOWMETRY; DISEASE COURSE; EDITORIAL; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; GENETIC VARIABILITY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RETINA BLOOD VESSEL; RETINA VEIN OCCLUSION; RISK FACTOR;

AMINO ACID OXIDOREDUCTASES; ELASTIC TISSUE; EXFOLIATION SYNDROME; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA; HOMOCYSTEINE; HUMANS; ISCHEMIA; MUTATION; PROTEIN-LYSINE 6-OXIDASE; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 45149125616     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.6.859     Document Type: Editorial

References (51)

1. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317(5843):1397-1400.
2. Oleggini R, Gastaldo N, Di Donato A. Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-β1 effects. Matrix Biol. 2007;26(6):494-505.
3. Fingert JH, Alward WL, Kwon YH, et al. LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States. Am J Ophthalmol. 2007;144(6):974-975.
4. Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36(2):178-182.
5. Kuhlenbäumer G, Friedrichs F, Kis B, et al. Association between single nucleotide polymorphisms in the lysyl oxidase-like 1 gene and spontaneous cervical artery dissection. Cerebrovasc Dis. 2007;24(4):343-348.
6. Gilad GM, Kagan HM, Gilad VH. Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci Lett. 2005;376(3):210-214.
7. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45(4):265-315.
8. Ritch R. Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J Glaucoma. 1994;3:176-178.
9. Bengtsson B, Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma. 2005;14(2):135-138.
10. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: The Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48-56.
11. Grødum K, Heijl A, Bengtsson B. Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology. 2005;112(3):386-390.
12. Schlötzer-Schrehardt UM, Koca MR, Naumann GOH, Volkholz H. Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110(12):1752-1756.
13. Streeten BW, Li ZY, Wallace RN, Eagle RCJ, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110(12):1757-1762.
14. Repo LP, Teräsvirta ME, Koivisto KJ. Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology. 1993;100(3):352-355.
15. Hagadus RJ, Wandel T, Ritch R, et al. Pseudoexfoliation in patients with Alzheimer's disease [ARVO abstract]. Invest Ophthalmol Vis Sci. 1989;30(suppl):27.
16. Linnér E, Popovic V, Gottfries CG, et al. The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand. 2001;79(3):283-285.
17. Janciauskiene S, Krakau T. Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome, and Alzheimer's disease. Acta Ophthalmol Scand. 2001;79(3):328-329.
18. Shaban RI, Asfour WM. Ocular pseudoexfoliation associated with hearing loss. Saudi Med J. 2004;25(9):1254-1257.
19. Aydoǧan Ozkan B, Yuksel N, Keskin G, et al. Homocysteine levels in plasma and sensorineural hearing loss in patients with pseudoexfoliation syndrome. Eur J Ophthalmol. 2006;16(4):542-547.
20. Cahill M, Early A, Stack S, Blayney AW, Eustace P. Pseudoexfoliation and sensorineural hearing loss. Eye. 2002;16(3):261-266.
21. Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation with increased vascular risk. Am J Ophthalmol. 1997;124(5):685-687.
22. Allingham RR, Loftsdottir M, Gottfredsdottir MS, et al. Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol. 2001;85(6):702-707.
23. Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol Scand. 1997;75(3):255-256.
24. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol. 2000;129(1):83-86.
25. Hammer T, Schlötzer-Schrehardt U, Naumann GOH. Unilateral or asymmetric pseudoexfoliation syndrome? an ultrastructural study. Arch Ophthalmol. 2001;119(7):1023-1031.
26. Laatikainen L. Fluorescein angiographic studies of the peripapillary and perilimbal regions in simple, capsular and low-tension glaucoma. Acta Ophthalmol Suppl. 1971;111:3-83.
27. Holló G, Lakatos P, Farkas K. Cold pressor test and plasma endothelin-1 concentration in primary open-angle glaucoma and capsular glaucoma. J Glaucoma. 1998;7(2):105-110.
28. Yüksel N, Anik Y, Kilic A, Karabas V, Demirci A, Caglar Y. Cerebrovascular blood flow velocities in pseudoexfoliation. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):316-321.
29. Yüksel N, Karabas VL, Arslan A, et al. Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology. 2001;108(6):1043-1049.
30. Scullica L, Buceti R, Castagna I, Ferreri G, Trombetta CJ. Functional aspects of pseudoexfoliation: physiopathological features. New Trends Ophthalmol. 1993;8:163-168.
31. Sibour G, Finazzo C, Boles Carenini A. Monolateral pseudoexfoliatio capsulae: a study of choroidal blood flow. Acta Ophthalmol Scand Suppl. 1997;75(224):13-14.
32. Yüksel N, Karabas VL, Demirci A, et al. Comparison of blood flow velocities of the extraocular vessels in patients with pseudoexfoliation or primary open-angle glaucoma. Ophthalmologica. 2001;215(6):424-429.
33. Harju M, Vesti E. Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2001;239(4):271-277.
34. Koliakos GG, Konstas AGP, Schlötzer-Schrehardt U, et al. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol. 2004;88(4):523-527.
35. Visontai Z, Merisch BM, Kollai M, Hollo G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma [published online ahead of print February 17, 2006]. Br J Ophthalmol. 2006;90(5):563-567. doi:10.1136/bjo.2005.087908.
36. Irkec M. Exfoliation and carotid stiffness [editorial]. Br J Ophthalmol. 2006;90(5):529-530.
37. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr. 2006;136(6)(suppl):1726S-1730S.
38. Roedl JB, Bleich S, Reulbach U, et al. Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma. 2007;16(2):234-239.
39. Vessani RM, Liebmann JM, Jofe M, Ritch R. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136(1):41-46.
40. Altintas O, Maral H, Yuksel N, Karabas VL, Dillioglugil MO, Caglar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma [published online ahead of print February 2, 2005]. Graefes Arch Clin Exp Ophthalmol. 2005;243(7):677-683. doi:10.1007/s00417-004-1097-2.
41. Puustjärvi T, Blomster H, Kontkanen M, et al. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2004;242(9):749-754.
42. Bleich S, Roedl J, Von Ahsen N, et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138(1):162-164.
43. Leibovitch I, Kurtz S, Shemesh G, et al. Hyperhomocystinemia in pseudoexfoliation glaucoma. J Glaucoma. 2003;12(1):36-39.
44. Zee RY, Mora S, Cheng S, et al. Homocysteine, 5,10- methylenetetrahydrofolate reductase 677C > T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem. 2007;53(5):845-851.
45. Lobo A, Naso A, Arheart K, et al. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am J Cardiol. 1999;83(6):821-825.
46. Roedl JB, Bleich S, Reulbach U, et al. Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm. 2007;114(5):571-575.
47. Raposo B, Rodriguez C, Martínez-Gonzáles J, Badimon L. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis. 2004;177(1):1-8.
48. Rodríguez C, Alcudia JF, Martínez-González J, et al. Lysyl oxidase (LOX) downregulation by TNFα: a new mechanism underlying TNFα-induced endothelial dysfunction [published online ahead of print August 1, 2007]. Atherosclerosis. 2008;196(2):558-564. doi:10.1016/j.atherosclerosis.2007.06.002.
49. Starcher B, Hill CH. Elastin defects in the lungs of avian and murine models of homocysteinemia. Exp Lung Res. 2005;31(9-10):873-885.
50. Schlötzer-Schrehardt U, Küchle M, Rummelt C, Naumann GOH. Role of transforming growth factor-b and its latent form binding protein in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 1999;40:S278.
51. Konstas AGP, Koliakos GG, Karabatsas CH, et al. Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp Eye Res. 2006;82(2):319-322.